These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12140044)

  • 1. Adverse reaction characterized by chest pain, shortness of breath, and syncope associated with verteporfin (visudyne).
    Cahill MT; Smith BT; Fekrat S
    Am J Ophthalmol; 2002 Aug; 134(2):281-2. PubMed ID: 12140044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactoid reaction after verteporfin therapy.
    Doshi AB; Moshfeghi DM; Jack RL
    Am J Ophthalmol; 2005 Nov; 140(5):936-7. PubMed ID: 16310483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous diclofenac as prophylactic treatment for verteporfin-associated low back pain.
    Theelen T; Hoyng CB
    Eur J Ophthalmol; 2008; 18(5):805-8. PubMed ID: 18850562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verteporfin infusion-associated pain.
    Borodoker N; Spaide RF; Maranan L; Murray J; Freund KB; Slakter JS; Sorenson JA; Yannuzzi LA; Guyer DR; Fisher YL
    Am J Ophthalmol; 2002 Feb; 133(2):211-4. PubMed ID: 11812424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications after photodynamic therapy.
    Schnurrbusch UE; Jochmann C; Einbock W; Wolf S
    Arch Ophthalmol; 2005 Oct; 123(10):1347-50. PubMed ID: 16219725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back pain after photodynamic therapy with verteporfin.
    Pece A; Vadalà M; Manzi R; Calori G
    Am J Ophthalmol; 2006 Mar; 141(3):593-4. PubMed ID: 16490525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
    Arnold JJ; Blinder KJ; Bressler NM; Bressler SB; Burdan A; Haynes L; Lim JI; Miller JW; Potter MJ; Reaves A; Rosenfeld PJ; Sickenberg M; Slakter JS; Soubrane G; Strong HA; Stur M; ;
    Am J Ophthalmol; 2004 Apr; 137(4):683-96. PubMed ID: 15059708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest pain on verteporfin.
    Prescrire Int; 2003 Feb; 12(63):17. PubMed ID: 12602378
    [No Abstract]   [Full Text] [Related]  

  • 10. Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome.
    Kang SW; Kang SJ; Kim HO; Nam ES; Lee JH; Koh HJ
    Am J Ophthalmol; 2002 Dec; 134(6):907-8. PubMed ID: 12470762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study.
    Kaiser PK; Boyer DS; Cruess AF; Slakter JS; Pilz S; Weisberger A;
    Ophthalmology; 2012 May; 119(5):1001-10. PubMed ID: 22444829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute respiratory distress due to verteporfin infusion for photodynamic therapy.
    Fossarello M; Peiretti E
    Arch Ophthalmol; 2006 Oct; 124(10):1509-10. PubMed ID: 17030732
    [No Abstract]   [Full Text] [Related]  

  • 13. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
    Keam SJ; Scott LJ; Curran MP
    Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy.
    Kotoula MG; Tsironi EE; Karabatsas CH; Chatzoulis DZ
    Retina; 2005 Jan; 25(1):102-3. PubMed ID: 15655455
    [No Abstract]   [Full Text] [Related]  

  • 15. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.
    Lui H; Hobbs L; Tope WD; Lee PK; Elmets C; Provost N; Chan A; Neyndorff H; Su XY; Jain H; Hamzavi I; McLean D; Bissonnette R
    Arch Dermatol; 2004 Jan; 140(1):26-32. PubMed ID: 14732656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
    Koh A; Lee WK; Chen LJ; Chen SJ; Hashad Y; Kim H; Lai TY; Pilz S; Ruamviboonsuk P; Tokaji E; Weisberger A; Lim TH
    Retina; 2012 Sep; 32(8):1453-64. PubMed ID: 22426346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil margination as a possible mechanism for verteporfin infusion-associated pain.
    Spaide RF; Maranan L
    Am J Ophthalmol; 2003 Apr; 135(4):549-50. PubMed ID: 12654380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.
    Reinke MH; Canakis C; Husain D; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.